DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
29 hedge funds and large institutions have $351K invested in DMK Pharmaceuticals Corporation Common Stock in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
29
Holding in Top 10
–
Calls
$76K
Puts
–
Top Buyers
| 1 | +$72.5K | |
| 2 | +$50.1K | |
| 3 | +$28.8K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.9K |
Top Sellers
| 1 | -$9.13K | |
| 2 | -$8.29K | |
| 3 | -$8.16K | |
| 4 |
BlackRock
New York
|
-$557 |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$69 |